ABX Diagnostics Inc Recalls

FDA
5
Total Recalls
1
Agencies
Sep 2005
First Recall
Jun 2014
Latest Recall

Showing 1-5 of 5 recalls

FDA

ABX Diagnostices Pentra 60C+ Hematology Analyzer

Instrument fails to obtain correct patient information/results due to malfunction of the equipment's sample door.

The firm distributed a 'Product Advisory Note' on June 5, 2003 by mail which includes instructions on how to avoid problems. It also mentions a new software release which will fix the problem.

FDA

ABX Pentra 120,120R,120DX, automated hematology analyzer

Labels can be incorrectly placed on a sample tube resulting in a possible error in results attributed to a sample.

Notifications have been prepared advising that following an occurrence observed outside of the United States, HORIBAABX is providing information regarding the rare circumstance of a label being incorrectly placed on a sample tube, resulting in a possible error in results attributed to a sample. The March 24, 2006, letter identifies various conditions in which the anomaly occurs. In order to prevent this type of incident, the firm recommends that the customer ensure that the identification label is firmly attached to the sample tubes during their positioning or removal from the racks.

FDA

Pentra 80 and Pentra 80XL Hematology Analyzers

Software defect, instrument may erroneously give a result of '0' or '---'.

Firm sent a notification/recall letter on April 8, 2004. They plan to modify the software in August 2004.

FDA

PENTRA 120 and PENTRA 120 Retic Hematology Analyzer

Power failure having impact on software.

Firm sent a notification / recall letter and response card dated June 24,2004 and promised to provide software shortly.

FDA

Automated Differential Cell Counter

Device can generate overestimated platelet results.

Software problem, device may give overestimated platelet results.